Technical Articles
IL-31RA
What Is Canine IL-31: How the Itch Cytokine Drives Dermatitis Models
Canine IL-31 signals through IL-31RA/OSMR and drives chronic itch in atopic dermatitis. This article covers the mechanism and how recombinant canine IL-31 supports model work.
View details
- Immunity/Inflamma
- Canine IL-31
- IL-31RA
- OSMR
- pruritus
- atopic dermatitis
- itch model
- UA040130
Targeting IL-31RA: A New Mechanism and Prospect for Itching Treatment
The interleukin-31 receptor alpha subunit (IL-31RA) has become an important target in the treatment of chronic inflammatory skin diseases. As a receptor primarily expressed on the surface of peripheral sensory neurons and some immune cells, IL-31RA activates downstream signaling pathways upon binding to the ligand IL-31, directly participating in the generation and transmission of itch signals.
View details
- Immunity/Inflamma
- IL-31RA
- 1








